This compound is a steroid intermediate featuring a spirocyclic dioxolane ring system. It serves as a building block in the synthesis of steroid-based pharmaceuticals.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 5571-36-8
3,20-Bis(ethylenedioxy)-19-norpregna-5(10),9(11)-dien-17-ol
pharmaceutical intermediate
Androsta-4,8-diene-3,17-dione
pharmaceutical intermediate
Prasterone acetate
pharmaceutical intermediate
(R)-Methyl 4-((3R,5S,8S,9S,10S,13R,14S,17R)-3-(tert-butyldimethylsilyloxy)-10,13-dimethyl-7-(trimethylsilyloxy)-2,3,4,5,8,9,10,11,12,13,14,15,16,17-Tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoate
pharmaceutical intermediate
1-(tert-Butyl) 3-methyl 2,5-dihydro-1H-pyrrole-1,3-dicarboxylate
pharmaceutical intermediate
2-Bromo-5-hydroxypyridine
pharmaceutical intermediate
2,3-Dihydrobenzo[b]furan-5-carbaldehyde
pharmaceutical intermediate
N-Succinimidyl maleimidoacetate
pharmaceutical intermediate
(8S,13S,14S)-13-methylspiro[1,2,4,6,7,8,12,14,15,16-decahydrocyclopenta[a]phenanthrene-3,2'-1,3-dioxolane]-17-one
XUOQKQRMICQUQC-AOIWGVFYSA-N
C[C@]12CC=C3[C@H]([C@@H]1CCC2=O)CCC4=C3CCC5(C4)OCCO5